Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer

Takashi Sato, Kenzo Soejima, Eri Arai, Junko Hamamoto, Hiroyuki Yasuda, Daisuke Arai, Kota Ishioka, Keiko Ohgino, Katsuhiko Naoki, Takashi Kohno, Koji Tsuta, Shun Ichi Watanabe, Yae Kanai, Tomoko Betsuyaku

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

PTPRH is a receptor-type protein tyrosine phosphatase thought to be a potential regulator of tumorigenesis. The aim of the present study was to clarify the significance of PTPRH expression and its regulation by DNA methylation in non-small cell lung cancer (NSCLC), especially in lung adenocarcinoma (LADC). PTPRH mRNA expression was examined in 89 NSCLC and corresponding non-cancerous tissues. The correlation between DNA methylation and PTPRH gene expression was investigated in another cohort that consisted of 145 patients with LADC, a major NSCLC subtype. Gene regulation by DNA methylation was assessed using a DNA methylation inhibitor. PTPRH mRNA expression was significantly upregulated in NSCLC. PTPRH DNA methylation was reduced in LADC samples and inversely correlated with mRNA expression. 5-Aza-2'-deoxycytidine treatment of lung cancer cell lines with low PTPRH expression, restored mRNA PTPRH expression levels. Furthermore, low PTPRH methylation was associated with shorter recurrence-free survival (P=1.64x10-4) and overall survival (P=5.54x10-5). Multivariate analysis revealed that PTPRH DNA methylation was an independent prognostic factor (P=6.88x10-3). It was confirmed that PTPRH is overexpressed in NSCLC. Furthermore, we determined that PTPRH is epigenetically regulated by DNA hypomethylation, with prognostic implications for LADC.

Original languageEnglish
Pages (from-to)1137-1145
Number of pages9
JournalOncology Reports
Volume34
Issue number3
DOIs
Publication statusPublished - 2015 Sep 1

Fingerprint

DNA Methylation
Non-Small Cell Lung Carcinoma
Messenger RNA
decitabine
Protein Tyrosine Phosphatases
Survival
Methylation
Lung Neoplasms
Carcinogenesis
Multivariate Analysis
Gene Expression
Recurrence
Cell Line
Adenocarcinoma of lung
DNA
Genes

Keywords

  • DNA methylation
  • Hypomethylation
  • Non-small cell lung cancer
  • Prognostic factor
  • PTPRH

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer. / Sato, Takashi; Soejima, Kenzo; Arai, Eri; Hamamoto, Junko; Yasuda, Hiroyuki; Arai, Daisuke; Ishioka, Kota; Ohgino, Keiko; Naoki, Katsuhiko; Kohno, Takashi; Tsuta, Koji; Watanabe, Shun Ichi; Kanai, Yae; Betsuyaku, Tomoko.

In: Oncology Reports, Vol. 34, No. 3, 01.09.2015, p. 1137-1145.

Research output: Contribution to journalArticle

Sato, T, Soejima, K, Arai, E, Hamamoto, J, Yasuda, H, Arai, D, Ishioka, K, Ohgino, K, Naoki, K, Kohno, T, Tsuta, K, Watanabe, SI, Kanai, Y & Betsuyaku, T 2015, 'Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer', Oncology Reports, vol. 34, no. 3, pp. 1137-1145. https://doi.org/10.3892/or.2015.4082
Sato, Takashi ; Soejima, Kenzo ; Arai, Eri ; Hamamoto, Junko ; Yasuda, Hiroyuki ; Arai, Daisuke ; Ishioka, Kota ; Ohgino, Keiko ; Naoki, Katsuhiko ; Kohno, Takashi ; Tsuta, Koji ; Watanabe, Shun Ichi ; Kanai, Yae ; Betsuyaku, Tomoko. / Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer. In: Oncology Reports. 2015 ; Vol. 34, No. 3. pp. 1137-1145.
@article{01bdd2c48bb44a848ec1fa1e19c2924b,
title = "Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer",
abstract = "PTPRH is a receptor-type protein tyrosine phosphatase thought to be a potential regulator of tumorigenesis. The aim of the present study was to clarify the significance of PTPRH expression and its regulation by DNA methylation in non-small cell lung cancer (NSCLC), especially in lung adenocarcinoma (LADC). PTPRH mRNA expression was examined in 89 NSCLC and corresponding non-cancerous tissues. The correlation between DNA methylation and PTPRH gene expression was investigated in another cohort that consisted of 145 patients with LADC, a major NSCLC subtype. Gene regulation by DNA methylation was assessed using a DNA methylation inhibitor. PTPRH mRNA expression was significantly upregulated in NSCLC. PTPRH DNA methylation was reduced in LADC samples and inversely correlated with mRNA expression. 5-Aza-2'-deoxycytidine treatment of lung cancer cell lines with low PTPRH expression, restored mRNA PTPRH expression levels. Furthermore, low PTPRH methylation was associated with shorter recurrence-free survival (P=1.64x10-4) and overall survival (P=5.54x10-5). Multivariate analysis revealed that PTPRH DNA methylation was an independent prognostic factor (P=6.88x10-3). It was confirmed that PTPRH is overexpressed in NSCLC. Furthermore, we determined that PTPRH is epigenetically regulated by DNA hypomethylation, with prognostic implications for LADC.",
keywords = "DNA methylation, Hypomethylation, Non-small cell lung cancer, Prognostic factor, PTPRH",
author = "Takashi Sato and Kenzo Soejima and Eri Arai and Junko Hamamoto and Hiroyuki Yasuda and Daisuke Arai and Kota Ishioka and Keiko Ohgino and Katsuhiko Naoki and Takashi Kohno and Koji Tsuta and Watanabe, {Shun Ichi} and Yae Kanai and Tomoko Betsuyaku",
year = "2015",
month = "9",
day = "1",
doi = "10.3892/or.2015.4082",
language = "English",
volume = "34",
pages = "1137--1145",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer

AU - Sato, Takashi

AU - Soejima, Kenzo

AU - Arai, Eri

AU - Hamamoto, Junko

AU - Yasuda, Hiroyuki

AU - Arai, Daisuke

AU - Ishioka, Kota

AU - Ohgino, Keiko

AU - Naoki, Katsuhiko

AU - Kohno, Takashi

AU - Tsuta, Koji

AU - Watanabe, Shun Ichi

AU - Kanai, Yae

AU - Betsuyaku, Tomoko

PY - 2015/9/1

Y1 - 2015/9/1

N2 - PTPRH is a receptor-type protein tyrosine phosphatase thought to be a potential regulator of tumorigenesis. The aim of the present study was to clarify the significance of PTPRH expression and its regulation by DNA methylation in non-small cell lung cancer (NSCLC), especially in lung adenocarcinoma (LADC). PTPRH mRNA expression was examined in 89 NSCLC and corresponding non-cancerous tissues. The correlation between DNA methylation and PTPRH gene expression was investigated in another cohort that consisted of 145 patients with LADC, a major NSCLC subtype. Gene regulation by DNA methylation was assessed using a DNA methylation inhibitor. PTPRH mRNA expression was significantly upregulated in NSCLC. PTPRH DNA methylation was reduced in LADC samples and inversely correlated with mRNA expression. 5-Aza-2'-deoxycytidine treatment of lung cancer cell lines with low PTPRH expression, restored mRNA PTPRH expression levels. Furthermore, low PTPRH methylation was associated with shorter recurrence-free survival (P=1.64x10-4) and overall survival (P=5.54x10-5). Multivariate analysis revealed that PTPRH DNA methylation was an independent prognostic factor (P=6.88x10-3). It was confirmed that PTPRH is overexpressed in NSCLC. Furthermore, we determined that PTPRH is epigenetically regulated by DNA hypomethylation, with prognostic implications for LADC.

AB - PTPRH is a receptor-type protein tyrosine phosphatase thought to be a potential regulator of tumorigenesis. The aim of the present study was to clarify the significance of PTPRH expression and its regulation by DNA methylation in non-small cell lung cancer (NSCLC), especially in lung adenocarcinoma (LADC). PTPRH mRNA expression was examined in 89 NSCLC and corresponding non-cancerous tissues. The correlation between DNA methylation and PTPRH gene expression was investigated in another cohort that consisted of 145 patients with LADC, a major NSCLC subtype. Gene regulation by DNA methylation was assessed using a DNA methylation inhibitor. PTPRH mRNA expression was significantly upregulated in NSCLC. PTPRH DNA methylation was reduced in LADC samples and inversely correlated with mRNA expression. 5-Aza-2'-deoxycytidine treatment of lung cancer cell lines with low PTPRH expression, restored mRNA PTPRH expression levels. Furthermore, low PTPRH methylation was associated with shorter recurrence-free survival (P=1.64x10-4) and overall survival (P=5.54x10-5). Multivariate analysis revealed that PTPRH DNA methylation was an independent prognostic factor (P=6.88x10-3). It was confirmed that PTPRH is overexpressed in NSCLC. Furthermore, we determined that PTPRH is epigenetically regulated by DNA hypomethylation, with prognostic implications for LADC.

KW - DNA methylation

KW - Hypomethylation

KW - Non-small cell lung cancer

KW - Prognostic factor

KW - PTPRH

UR - http://www.scopus.com/inward/record.url?scp=84937211885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937211885&partnerID=8YFLogxK

U2 - 10.3892/or.2015.4082

DO - 10.3892/or.2015.4082

M3 - Article

VL - 34

SP - 1137

EP - 1145

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 3

ER -